NewAmsterdam Pharma N.V. Insider Trades
NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $226.50K
- Sales
- 43 · $63.25M
- Shares bought / sold
- 10.00K / 1.97M
- Net activity
- Net selling $63.0 million
NewAmsterdam Pharma N.V. insider activity
Over the last 12 months, NewAmsterdam Pharma N.V. insiders reported 81 transactions on SEC Form 4: 1 open-market purchase and 43 sales. Insiders bought $226,500 and sold $63.3 million worth of stock, for net insider selling of $63.0 million. The largest seller was Davidson Michael H., with $25.3 million in reported sales.
The most recent filing shows Kastelein Johannes Jacob Pieter (Chief Scientific Officer) reporting a transaction in 50,246 shares on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NAMS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NAMS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 50,246 | $1.26M | Form 4 |
| Sep 30, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | 50,246 | — | Form 4 |
| Sep 14, 2026 | Davidson Michael H.Chief Executive Officer | Buy | 10,000 | $226.50K | Form 4 |
| Sep 4, 2026 | Smither John WDirector | Sale | 1,600 | $40.51K | Form 4 |
| Sep 1, 2026 | Gunning Robert WilliamVice President, Controller | Award | 3,200 | — | Form 4 |
| Aug 24, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 125,000 | $3.36M | Form 4 |
| Aug 24, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | 125,000 | — | Form 4 |
| Jul 20, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 2,915 | $92.43K | Form 4 |
| Jul 20, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 31,885 | $990.03K | Form 4 |
| Jul 20, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 70,200 | $2.10M | Form 4 |
| Jul 20, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 80,000 | $893.60K | Form 4 |
| Jul 20, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 25,000 | $297.50K | Form 4 |
| Jun 22, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 300 | $9.22K | Form 4 |
| Jun 22, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 39,700 | $1.20M | Form 4 |
| Jun 22, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 15,000 | $178.50K | Form 4 |
| Jun 22, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 25,000 | $272.50K | Form 4 |
| May 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 65,000 | $2.32M | Form 4 |
| May 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 5,000 | $54.50K | Form 4 |
| May 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 60,000 | $600.00K | Form 4 |
| Mar 11, 2026 | LANGE LOUIS GDirector | Sale | 446 | $13.93K | Form 4 |
| Mar 11, 2026 | LANGE LOUIS GDirector | Sale | 44,173 | $1.34M | Form 4 |
| Mar 9, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 101,409 | $3.07M | Form 4 |
| Mar 9, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | 101,409 | — | Form 4 |
| Mar 9, 2026 | LANGE LOUIS GDirector | Option exercise | 44,619 | $513.12K | Form 4 |
| Mar 6, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 94,124 | $2.85M | Form 4 |
| Mar 6, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | 94,124 | — | Form 4 |
| Mar 6, 2026 | LANGE LOUIS GDirector | Sale | 28,186 | $828.95K | Form 4 |
| Mar 5, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 104,467 | $3.17M | Form 4 |
| Mar 5, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Option exercise | 104,467 | — | Form 4 |
| Mar 2, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 443,707 | $14.75M | Form 4 |
| Mar 2, 2026 | Davidson Michael H.Chief Executive Officer | Option exercise | 443,707 | — | Form 4 |
| Feb 26, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 17,924 | $617.30K | Form 4 |
| Feb 26, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 165,408 | $5.56M | Form 4 |
| Feb 26, 2026 | Davidson Michael H.Chief Executive Officer | Option exercise | 183,332 | — | Form 4 |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 1,300 | $47.68K | Form 4 |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 10,436 | $375.28K | Form 4 |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 46,517 | $1.63M | Form 4 |
| Feb 25, 2026 | Davidson Michael H.Chief Executive Officer | Option exercise | 58,253 | — | Form 4 |
| Feb 24, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 3,161 | $115.25K | Form 4 |
| Feb 24, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 61,547 | $2.22M | Form 4 |
| Feb 24, 2026 | Davidson Michael H.Chief Executive Officer | Option exercise | 64,708 | — | Form 4 |
| Feb 20, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 30,789 | $1.09M | Form 4 |
| Feb 20, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 14,692 | $514.22K | Form 4 |
| Jan 28, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 32,612 | $1.04M | Form 4 |
| Jan 28, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 32,612 | $355.47K | Form 4 |
| Jan 27, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 39,816 | $1.30M | Form 4 |
| Jan 27, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 39,816 | $433.99K | Form 4 |
| Jan 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 309 | $10.34K | Form 4 |
| Jan 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 34,091 | $1.12M | Form 4 |
| Jan 26, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 34,400 | $374.96K | Form 4 |
| Jan 23, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 12,767 | $438.80K | Form 4 |
| Jan 23, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 25,405 | $849.54K | Form 4 |
| Jan 23, 2026 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 38,172 | $416.07K | Form 4 |
| Jan 21, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 24,362 | $823.44K | Form 4 |
| Jan 21, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 15,422 | $512.78K | Form 4 |
| Jan 21, 2026 | Somaiya Mayur IanChief Financial Officer | Option exercise | 39,784 | $368.40K | Form 4 |
| Jan 20, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 19,604 | $634.78K | Form 4 |
| Jan 20, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 39,712 | $1.26M | Form 4 |
| Jan 20, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 900 | $27.58K | Form 4 |
| Jan 20, 2026 | Somaiya Mayur IanChief Financial Officer | Option exercise | 60,216 | $557.60K | Form 4 |
| Jan 7, 2026 | Somaiya Mayur IanChief Financial Officer | Award | 25,500 | — | Form 4 |
| Jan 7, 2026 | Kooij Louise FrederikaChief Accounting Officer | Award | 12,000 | — | Form 4 |
| Jan 7, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Award | 25,500 | — | Form 4 |
| Jan 7, 2026 | Smither John WDirector | Award | 3,400 | — | Form 4 |
| Jan 7, 2026 | Lewis WilliamDirector | Award | 3,400 | — | Form 4 |
| Jan 7, 2026 | Gulfo Adele M.Director | Award | 3,400 | — | Form 4 |
| Jan 7, 2026 | LANGE LOUIS GDirector | Award | 3,400 | — | Form 4 |
| Jan 7, 2026 | McKenna Mark C.Director | Award | 3,400 | — | Form 4 |
| Jan 7, 2026 | Davidson Michael H.Chief Executive Officer | Award | 81,000 | — | Form 4 |
| Jan 7, 2026 | Davidson Michael H.Chief Executive Officer | Sale | 11,582 | — | Form 4 |
| Jan 7, 2026 | van der Kamp Hilde JohannaDirector | Award | 3,400 | — | Form 4 |
| Jan 5, 2026 | Somaiya Mayur IanChief Financial Officer | Sale | 5,118 | $170.17K | Form 4 |
| Jan 5, 2026 | Kooij Louise FrederikaChief Accounting Officer | Sale | 2,647 | $88.01K | Form 4 |
| Jan 5, 2026 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 6,000 | $199.50K | Form 4 |
| Dec 26, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 43,872 | $1.55M | Form 4 |
| Dec 26, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 5,000 | $54.50K | Form 4 |
| Dec 26, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 38,872 | $388.72K | Form 4 |
| Dec 24, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 26,011 | $928.07K | Form 4 |
| Dec 24, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 26,011 | $260.11K | Form 4 |
| Dec 23, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 75,117 | $2.72M | Form 4 |
| Dec 23, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 75,117 | $751.17K | Form 4 |
| Sep 15, 2025 | Topper James NDirector | Buy | 660 | $15.64K | Form 4 |
| Sep 9, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 96,896 | $2.53M | Form 4 |
| Sep 9, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 53,104 | $1.34M | Form 4 |
| Sep 9, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 150,000 | $1.50M | Form 4 |
| Sep 8, 2025 | Topper James NDirector | Buy | 1,260 | $31.49K | Form 4 |
| Sep 3, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 18,073 | $453.45K | Form 4 |
| Sep 2, 2025 | Kooij Louise FrederikaChief Accounting Officer | Option exercise | 18,073 | — | Form 4 |
| Aug 25, 2025 | Kooij Louise FrederikaChief Accounting Officer | Sale | 8,269 | $205.57K | Form 4 |
| Aug 22, 2025 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 7,658 | $195.20K | Form 4 |
| Aug 22, 2025 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 42,342 | $1.06M | Form 4 |
| Aug 21, 2025 | Kastelein Johannes Jacob PieterChief Scientific Officer | Sale | 50,000 | $1.21M | Form 4 |
| Aug 11, 2025 | Topper James NDirector | Buy | 471 | $11.29K | Form 4 |
| Jul 16, 2025 | Kling Douglas FChief Operating Officer | Sale | 51,043 | $1.08M | Form 4 |
| Jul 16, 2025 | Kling Douglas FChief Operating Officer | Option exercise | 51,043 | $556.37K | Form 4 |
| Jul 15, 2025 | Kling Douglas FChief Operating Officer | Sale | 3,544 | $78.39K | Form 4 |
| Jul 15, 2025 | Kling Douglas FChief Operating Officer | Sale | 44,025 | $941.25K | Form 4 |
| Jul 15, 2025 | Kling Douglas FChief Operating Officer | Option exercise | 47,569 | $518.50K | Form 4 |
| Jun 25, 2025 | Topper James NDirector | Buy | 1,260 | $23.01K | Form 4 |
| Jun 24, 2025 | Topper James NDirector | Buy | 2,520 | $46.45K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4